Product image of Mometasona Ratiopharm (Mometasone Furoate) supplied by GNH India

Mometasona Ratiopharm

Active Ingredient:
Mometasone Furoate
Origin:
EU

Mometasona Ratiopharm (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Ratiopharm, is a corticosteroid presented as a topical formulation for skin use. It is employed to manage inflammatory dermatoses such as psoriasis, atopic dermatitis, allergic contact dermatitis and seborrheic dermatitis, reducing redness, scaling and itching in affected patients.

GNH India supplies Mometasona Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ratiopharm-Comercio E Industria De Produtos Farmaceuticos Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone furoate is a potent topical corticosteroid used to treat inflammatory skin conditions.

  • Psoriasis: reduces inflammation and scaling, improving skin appearance.
  • Atopic dermatitis: alleviates itching and erythema, restoring barrier function.
  • Allergic contact dermatitis: suppresses allergic inflammation and relieves symptoms.
  • Seborrheic dermatitis: controls flaking and redness on scalp and facial areas.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction down‑regulates pro‑inflammatory cytokines, chemokines and adhesion molecules while up‑regulating anti‑inflammatory proteins, resulting in decreased cellular infiltration, edema and immune activation in the skin.

Side Effects

Topical application of mometasone furoate may cause local skin reactions and, rarely, systemic effects.

Common Side Effects

  • Burning or stinging sensation at the application site.
  • Pruritus or mild itching.
  • Dryness or flaking of the skin.
  • Erythema or mild redness.
  • Folliculitis or small pimples.
  • Skin irritation or contact dermatitis.

Serious or Rare Side Effects

  • Skin atrophy or thinning with prolonged use.
  • Secondary bacterial, fungal or viral infection of the treated area.
  • Hypersensitivity reactions such as urticaria or angioedema.
  • Systemic corticosteroid effects (e.g., adrenal suppression) after extensive application.
  • Delayed wound healing.
  • Hypertrichosis (excessive hair growth) in the treated region.

Precautions & Warnings

When using Mometasona Ratiopharm, consider the following precautions to ensure safe and effective therapy.

  • Assess severity: limit use to mild‑moderate disease and avoid prolonged continuous application.
  • Avoid occlusion: do not cover treated skin with airtight dressings unless directed by a clinician.
  • Monitor for infection: discontinue if signs of bacterial, fungal or viral infection develop.
  • Use minimal amount: apply the thinnest film necessary to cover the affected area.
  • Pediatric use: exercise caution in children due to higher per‑body‑surface absorption.
  • Store at room temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Mometasone furoate may interact with other agents that affect corticosteroid activity or skin integrity. Major Interactions (Avoid):\n- Systemic corticosteroids: additive systemic glucocorticoid effects may increase risk of adrenal suppression.

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug concentration, enhancing side‑effects.

Moderate Interactions (Monitor Closely)

  • Topical antifungal agents: concurrent use may increase irritation risk.
  • Antibiotic creams or ointments: may alter skin flora and affect healing.
  • Phototherapy: combined use can heighten skin sensitivity to light.
  • Other potent topical steroids: may cause excessive local immunosuppression.
  • Skin barrier‑disrupting products (e.g., harsh cleansers): can increase absorption and irritation.

Frequently Asked Questions

Mometasona Ratiopharm contains mometasone furoate, a topical corticosteroid indicated for inflammatory skin disorders such as psoriasis, atopic dermatitis, allergic contact dermatitis and seborrheic dermatitis. It helps reduce redness, scaling, itching and swelling associated with these conditions.

Mometasone furoate binds to glucocorticoid receptors inside skin cells, altering gene transcription. This suppresses the production of pro‑inflammatory cytokines and chemokines while enhancing anti‑inflammatory proteins, leading to decreased immune cell infiltration, reduced edema and relief of skin inflammation.

The specific dose and frequency of Mometasona Ratiopharm are determined by the prescribing clinician based on the severity of the skin condition, the area to be treated and patient factors. Patients should follow the healthcare professional’s instructions and not adjust the regimen on their own.

Safety data for mometasone furoate in pregnancy and lactation are limited. Healthcare providers usually weigh potential benefits against possible risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.

To request Mometasona Ratiopharm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone furoate is a high‑potency corticosteroid, offering strong anti‑inflammatory effects with once‑daily application in many cases. Compared with lower‑potency agents such as hydrocortisone, it provides faster symptom control but may carry a higher risk of local side effects if used excessively. Choice of therapy depends on disease severity and treatment goals.

Store Mometasona Ratiopharm at room temperature below 25 °C. Keep the product in its original container, protect it from moisture, heat and direct sunlight, and ensure the packaging is tightly closed when not in use.

Mometasona Ratiopharm is applied topically to clean, dry skin. A thin layer should be spread over the affected area, usually once or twice daily as directed by a healthcare professional. Hands should be washed before and after application, and the treated area should not be covered with airtight dressings unless advised.

Serious risks, though uncommon, include skin atrophy, secondary infections, systemic absorption leading to adrenal suppression, and severe allergic reactions such as urticaria or angioedema. Patients should report any unusual skin changes, signs of infection or systemic symptoms to their clinician promptly.

Mometasona Ratiopharm should be avoided in individuals with known hypersensitivity to mometasone furoate or any excipients in the formulation. It is also contraindicated on infected skin unless the infection is being treated concurrently, and caution is advised in children, pregnant or lactating women, and patients requiring long‑term systemic corticosteroid therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT